Evidence map›Paper›PMID 26408913›Full record

ArticleApplied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine2016

Automated production of [¹⁸F]VAT suitable for clinical PET study of vesicular acetylcholine transporter.

Xuyi Yue, Christopher Bognar, Xiang Zhang, Gregory G Gaehle, Stephen M Moerlein, Joel S Perlmutter, Zhude Tu

Abstract read
In one paragraph

Article in Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. PET Quantification of [Journal of nuclear medicine : official publication, Society of Nuclear Medicine · 2024
    Article
  6. An improved synthesis of [Journal of labelled compounds & radiopharmaceuticals · 2023
    Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. PET Imaging in Movement Disorders.Seminars in nuclear medicine · 2018
    Review
  12. Article
  13. Article
  14. Kinetic modeling of [Journal of neurochemistry · 2018
    Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Xuyi YueMallinckrodt Institute of Radiology, Washington University School of Medicine, St. Louis, MO, USA.
Christopher BognarMallinckrodt Institute of Radiology, Washington University School of Medicine, St. Louis, MO, USA.
Xiang ZhangMallinckrodt Institute of Radiology, Washington University School of Medicine, St. Louis, MO, USA.
Gregory G GaehleMallinckrodt Institute of Radiology, Washington University School of Medicine, St. Louis, MO, USA.
Stephen M MoerleinMallinckrodt Institute of Radiology, Washington University School of Medicine, St. Louis, MO, USA.
Joel S PerlmutterMallinckrodt Institute of Radiology, Washington University School of Medicine, St. Louis, MO, USA.
Zhude TuMallinckrodt Institute of Radiology, Washington University School of Medicine, St. Louis, MO, USA. Electronic address: tuz@mir.wustl.edu.

Funding

INVESTIGATIONS OF DEMENTIA IN PARKINSON DISEASER01NS075321 · NINDS · WASHINGTON UNIVERSITY · PI CAMPBELL, MEGHAN C, PERLMUTTER, JOEL SYNES · 2011 to 2021
$8.2M
PET PROBES FOR IMAGING THE VESICULAR ACETYLCHOLINE TRANSPORTERR01NS075527 · NINDS · WASHINGTON UNIVERSITY · PI TU, ZHUDE · 2011 to 2021
$4.9M
DEVELOPING PET AGENTS FOR IMAGING PHOSPHODIESTERASE 10A (PDE10A)R33MH092797 · NIMH · WASHINGTON UNIVERSITY · PI TU, ZHUDE · 2013 to 2015
$1.5M
DEVELOPMENT OF VESICULAR ACETYLCHOLINE TRANSPORTER IMAGING AGENTS FOR PETR21NS061025 · NINDS · WASHINGTON UNIVERSITY · PI TU, ZHUDE · 2009 to 2010
$628k
DEVELOPING PET AGENTS FOR IMAGING PHOSPHODIESTERASE 10A (PDE10A)R21MH092797 · NIMH · WASHINGTON UNIVERSITY · PI TU, ZHUDE · 2011 to 2012
$530k
NIMH NIH HHS MH092797NIMH NIH HHS R21 MH092797NIMH NIH HHS R33 MH092797NINDS NIH HHS NS061025NINDS NIH HHS NS075527NINDS NIH HHS R01 NS075321NINDS NIH HHS R01 NS075527NINDS NIH HHS R21 NS061025
6 · The paper itself

Abstract

Automated production of a promising radiopharmaceutical (-)-(1-(8-(2-[(18)F]fluoroethoxy)-3-hydroxy-1,2,3,4-tetrahydronaphthalen-2-yl)-piperidin-4-yl)(4-fluorophenyl)methanone ([(18)F]VAT) for the vesicular acetylcholine transporter(VAChT) was achieved using a two-step procedure in a current Good Manufacturing Practices fashion. The production of [(18)F]VAT was accomplished in approximately 140 min, with radiochemical yield of ~15.0% (decay corrected), specific activity>111 GBq/µmol, radiochemical purity>99% and mass of VAT ~3.4 μg/batch (n>10). The radiopharmaceutical product meets all quality control criteria for human use, and is suitable for clinical PET studies of VAChT.

Indexed as

Fluorine RadioisotopesHumansMolecular StructureNaphtholsPiperidinesPositron-Emission TomographyQuality ControlRadiopharmaceuticalsVesicular Acetylcholine Transport Proteins(1-(8-(2-fluoroethoxy)-3-hydroxy-1,2,3,4-tetrahydronaphthalen-2-yl)piperidin-4-yl)(4-fluorophenyl)methanoneFluorine RadioisotopesNaphtholsPiperidinesRadiopharmaceuticalsSLC18A3 protein, humanVesicular Acetylcholine Transport ProteinsAutomationClinical studiesFluorine-18Positron emission tomographyVesicular acetylcholine transporter

Identifiers

PMID26408913
PMCPMC4681605

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.